Ubiquilin-1 overexpression increases the lifespan and delays accumulation of Huntingtin aggregates in the R6/2 mouse model of Huntington's disease.
Huntington's Disease (HD) is a neurodegenerative disorder that is caused by abnormal expansion of a polyglutamine tract in huntingtin (htt) protein. The expansion leads to increased htt aggregation and toxicity. Factors that aid in the clearance of mutant huntingtin proteins should relieve the...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2014-01-01
|
| Series: | PLoS ONE |
| Online Access: | http://europepmc.org/articles/PMC3903676?pdf=render |
| _version_ | 1811192098756493312 |
|---|---|
| author | Nathaniel Safren Amina El Ayadi Lydia Chang Chantelle E Terrillion Todd D Gould Darren F Boehning Mervyn J Monteiro |
| author_facet | Nathaniel Safren Amina El Ayadi Lydia Chang Chantelle E Terrillion Todd D Gould Darren F Boehning Mervyn J Monteiro |
| author_sort | Nathaniel Safren |
| collection | DOAJ |
| description | Huntington's Disease (HD) is a neurodegenerative disorder that is caused by abnormal expansion of a polyglutamine tract in huntingtin (htt) protein. The expansion leads to increased htt aggregation and toxicity. Factors that aid in the clearance of mutant huntingtin proteins should relieve the toxicity. We previously demonstrated that overexpression of ubiqulin-1, which facilitates protein clearance through the proteasome and autophagy pathways, reduces huntingtin aggregates and toxicity in mammalian cell and invertebrate models of HD. Here we tested whether overexpression of ubiquilin-1 delays or prevents neurodegeneration in R6/2 mice, a well-established model of HD. We generated transgenic mice overexpressing human ubiquilin-1 driven by the neuron-specific Thy1.2 promoter. Immunoblotting and immunohistochemistry revealed robust and widespread overexpression of ubiquilin-1 in the brains of the transgenic mice. Similar analysis of R6/2 animals revealed that ubiquilin is localized in huntingtin aggregates and that ubiquilin levels decrease progressively to 30% during the end-stage of disease. We crossed our ubiquilin-1 transgenic line with R6/2 mice to assess whether restoration of ubiquilin levels would delay HD symptoms and pathology. In the double transgenic progeny, ubiquilin levels were fully restored, and this correlated with a 20% increase in lifespan and a reduction in htt inclusions in the hippocampus and cortex. Furthermore, immunoblots indicated that endoplasmic reticulum stress response that is elevated in the hippocampus of R6/2 animals was attenuated by ubiquilin-1 overexpression. However, ubiquilin-1 overexpression neither altered the load of htt aggregates in the striatum nor improved motor impairments in the mice. |
| first_indexed | 2024-04-11T23:46:01Z |
| format | Article |
| id | doaj.art-e2477da94a82484587dd7fa7b6ab5b8e |
| institution | Directory Open Access Journal |
| issn | 1932-6203 |
| language | English |
| last_indexed | 2024-04-11T23:46:01Z |
| publishDate | 2014-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj.art-e2477da94a82484587dd7fa7b6ab5b8e2022-12-22T03:56:38ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-0191e8751310.1371/journal.pone.0087513Ubiquilin-1 overexpression increases the lifespan and delays accumulation of Huntingtin aggregates in the R6/2 mouse model of Huntington's disease.Nathaniel SafrenAmina El AyadiLydia ChangChantelle E TerrillionTodd D GouldDarren F BoehningMervyn J MonteiroHuntington's Disease (HD) is a neurodegenerative disorder that is caused by abnormal expansion of a polyglutamine tract in huntingtin (htt) protein. The expansion leads to increased htt aggregation and toxicity. Factors that aid in the clearance of mutant huntingtin proteins should relieve the toxicity. We previously demonstrated that overexpression of ubiqulin-1, which facilitates protein clearance through the proteasome and autophagy pathways, reduces huntingtin aggregates and toxicity in mammalian cell and invertebrate models of HD. Here we tested whether overexpression of ubiquilin-1 delays or prevents neurodegeneration in R6/2 mice, a well-established model of HD. We generated transgenic mice overexpressing human ubiquilin-1 driven by the neuron-specific Thy1.2 promoter. Immunoblotting and immunohistochemistry revealed robust and widespread overexpression of ubiquilin-1 in the brains of the transgenic mice. Similar analysis of R6/2 animals revealed that ubiquilin is localized in huntingtin aggregates and that ubiquilin levels decrease progressively to 30% during the end-stage of disease. We crossed our ubiquilin-1 transgenic line with R6/2 mice to assess whether restoration of ubiquilin levels would delay HD symptoms and pathology. In the double transgenic progeny, ubiquilin levels were fully restored, and this correlated with a 20% increase in lifespan and a reduction in htt inclusions in the hippocampus and cortex. Furthermore, immunoblots indicated that endoplasmic reticulum stress response that is elevated in the hippocampus of R6/2 animals was attenuated by ubiquilin-1 overexpression. However, ubiquilin-1 overexpression neither altered the load of htt aggregates in the striatum nor improved motor impairments in the mice.http://europepmc.org/articles/PMC3903676?pdf=render |
| spellingShingle | Nathaniel Safren Amina El Ayadi Lydia Chang Chantelle E Terrillion Todd D Gould Darren F Boehning Mervyn J Monteiro Ubiquilin-1 overexpression increases the lifespan and delays accumulation of Huntingtin aggregates in the R6/2 mouse model of Huntington's disease. PLoS ONE |
| title | Ubiquilin-1 overexpression increases the lifespan and delays accumulation of Huntingtin aggregates in the R6/2 mouse model of Huntington's disease. |
| title_full | Ubiquilin-1 overexpression increases the lifespan and delays accumulation of Huntingtin aggregates in the R6/2 mouse model of Huntington's disease. |
| title_fullStr | Ubiquilin-1 overexpression increases the lifespan and delays accumulation of Huntingtin aggregates in the R6/2 mouse model of Huntington's disease. |
| title_full_unstemmed | Ubiquilin-1 overexpression increases the lifespan and delays accumulation of Huntingtin aggregates in the R6/2 mouse model of Huntington's disease. |
| title_short | Ubiquilin-1 overexpression increases the lifespan and delays accumulation of Huntingtin aggregates in the R6/2 mouse model of Huntington's disease. |
| title_sort | ubiquilin 1 overexpression increases the lifespan and delays accumulation of huntingtin aggregates in the r6 2 mouse model of huntington s disease |
| url | http://europepmc.org/articles/PMC3903676?pdf=render |
| work_keys_str_mv | AT nathanielsafren ubiquilin1overexpressionincreasesthelifespananddelaysaccumulationofhuntingtinaggregatesinther62mousemodelofhuntingtonsdisease AT aminaelayadi ubiquilin1overexpressionincreasesthelifespananddelaysaccumulationofhuntingtinaggregatesinther62mousemodelofhuntingtonsdisease AT lydiachang ubiquilin1overexpressionincreasesthelifespananddelaysaccumulationofhuntingtinaggregatesinther62mousemodelofhuntingtonsdisease AT chantelleeterrillion ubiquilin1overexpressionincreasesthelifespananddelaysaccumulationofhuntingtinaggregatesinther62mousemodelofhuntingtonsdisease AT todddgould ubiquilin1overexpressionincreasesthelifespananddelaysaccumulationofhuntingtinaggregatesinther62mousemodelofhuntingtonsdisease AT darrenfboehning ubiquilin1overexpressionincreasesthelifespananddelaysaccumulationofhuntingtinaggregatesinther62mousemodelofhuntingtonsdisease AT mervynjmonteiro ubiquilin1overexpressionincreasesthelifespananddelaysaccumulationofhuntingtinaggregatesinther62mousemodelofhuntingtonsdisease |